Vizimpro

Vizimpro (dacomitinib) is an oral prescription medication used for certain types of non-small cell lung cancer. It belongs to the kinase inhibitor class and is taken once daily. Always follow healthcare provider instructions when using this treatment.

Vizimpro is prescribed to treat non-small cell lung cancer that has specific genetic mutations. It works by blocking signals that help cancer cells grow and spread. Patients often ask, 'what is dacomitinib used for' when researching treatment options. This medication is typically recommended for advanced or metastatic cases.

Like many cancer treatments, Vizimpro may cause side effects such as skin reactions, diarrhea, or fatigue. Some patients notice changes in appetite or nail growth. These effects vary widely between individuals and should be discussed with a healthcare provider.

Store Vizimpro at room temperature away from moisture and heat. Keep this medication in its original packaging until ready to use. Always handle with dry hands and avoid crushing or splitting tablets unless instructed by a pharmacist.

Dacomitinib may interact with other medications, including certain antibiotics, antifungals, or heart medications. Alcohol and grapefruit products can also affect how this drug works. Always inform your healthcare provider about all medications and supplements you're taking.